The administration of oral mucosal mesenchymal-derived stem cells improves hepatic inflammation, oxidative stress, and histopathology following traumatic brain injury

CONCLUSION: Therapy with i.v. OMSCs administration after TBI reduces liver injury, as measured by inflammation and oxidative stress. The use of OMSCs can be considered for treatment of liver injury caused by TBI.PMID:37918577 | DOI:10.1016/j.trim.2023.101950

Source: Transplant Immunology - November 2, 2023 Category: Transplant Surgery Authors: Eshagh Alizadeh Nazanin Sabet Zahra Soltani Mohammad Khaksari Elham Jafari Saeed Karamouzian Source Type: research